Devoĭno L V, Al'perina E L, Cheĭdo M A, Gevorgian M M
Eksp Klin Farmakol. 2004 May-Jun;67(3):48-50.
A highly selective dopamine D1 receptor agonist (compound SKF 38393) administered in a dose of 20 mg/kg produced a significant increase in the number of rosette-forming cells (RFCs) in the spleen of Wistar rats on the 5th day upon their immunization with goat erythrocytes (5 x 10(8)). At the same time, a specific blocker of these receptors (compound SCH 23390) in a dose of 0.5 or 1 mg/kg inhibited the immune response of rats. In C57BL/6J mice, SCH 23390 (0.25, 0.5, or 1 mg/kg) also significantly reduced the number of RFCs. Preliminary blockade of the D1 dopamine receptors with SCH 23390 (1 mg/kg) prevented the immunostimulating effect of SKF 38393. These data indicate that D1 dopamine receptors are involved in immunomodulation.
以20毫克/千克的剂量给予一种高选择性多巴胺D1受体激动剂(化合物SKF 38393),在用山羊红细胞(5×10⁸)免疫Wistar大鼠后的第5天,其脾脏中玫瑰花结形成细胞(RFCs)的数量显著增加。同时,剂量为0.5或1毫克/千克的这些受体的特异性阻断剂(化合物SCH 23390)抑制了大鼠的免疫反应。在C57BL/6J小鼠中,SCH 23390(0.25、0.5或1毫克/千克)也显著减少了RFCs的数量。用SCH 23390(1毫克/千克)对D1多巴胺受体进行预先阻断可防止SKF 38393的免疫刺激作用。这些数据表明D1多巴胺受体参与免疫调节。